Loading the SOTA2 catalog…
Ataraxis Breast
AI-native platform with clinically validated prognostic and predictive tools for breast cancer, including recurrence risk, chemotherapy benefit, and neoadjuvant response predict...
What is Ataraxis Breast?
AI-native platform with clinically validated prognostic and predictive tools for breast cancer, including recurrence risk, chemotherapy benefit, and neoadjuvant response prediction.
Product typeDiagnostics & Imaging
Pricing ·
Deployment
APINot available
What teams use Ataraxis Breast for
Cancer prognostics
Precision oncology
Digital pathology
Breast cancer diagnostics
Integrations and access
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Platforms
IntegrationsAPI and webhooks
Languages
Support
What reviewers say
Community reviewsReviews are owned and editable by their authors.
Sign in to reviewLoading community reviews…
Enterprise readiness
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.
HIPAA
Data retention:
Benchmarks and comparisons
Independent benchmarksStructured task results are being verified.
Side-by-side comparisonsComparison workspaces will be available in a later release.
